# CGRP-induced Migraine Attacks in Patients Who Have Tried Anti-CGRP Monoclonal Antibody Treatment

> **NCT03481400** · NA · UNKNOWN · sponsor: **Danish Headache Center** · enrollment: 40 (estimated)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** Calcitonin Gene-Related Peptide
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03481400
- **Lead sponsor:** Danish Headache Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-07
- **Primary completion:** 2019-09
- **Final completion:** 2019-09
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2018-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03481400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03481400, "CGRP-induced Migraine Attacks in Patients Who Have Tried Anti-CGRP Monoclonal Antibody Treatment". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03481400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*